Company-level financial information
NATIONAL HEALTHCARE CORP
Selected annual earnings and cash-flow facts from SEC filings. Each row identifies its exact reporting period and original filing.
Annual net income
| Reporting period | Measure | USD millions | Filing |
|---|---|---|---|
| Dec 31, 2025From Jan 1, 2025 | Operating cash flow | 185.1 | SEC filingFeb 26, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Net income | 120.0 | SEC filingFeb 26, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Common-stock cash dividends | 38.7 | SEC filingFeb 26, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Capital expenditures (PP&E) | 36.4 | SEC filingFeb 26, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Operating cash flow | 107.3 | SEC filingFeb 26, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Net income | 101.9 | SEC filingFeb 26, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Common-stock cash dividends | 37.0 | SEC filingFeb 26, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Capital expenditures (PP&E) | 27.6 | SEC filingFeb 26, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Operating cash flow | 111.2 | SEC filingFeb 26, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Net income | 66.8 | SEC filingFeb 26, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Common-stock cash dividends | 35.6 | SEC filingFeb 26, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Capital expenditures (PP&E) | 27.9 | SEC filingFeb 26, 2026 |
| Dec 31, 2022From Jan 1, 2022 | Operating cash flow | 8.7 | SEC filingMar 3, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Net income | 22.4 | SEC filingMar 3, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Common-stock cash dividends | 34.6 | SEC filingMar 3, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Capital expenditures (PP&E) | 30.2 | SEC filingMar 3, 2025 |
| Dec 31, 2021From Jan 1, 2021 | Operating cash flow | 62.4 | SEC filingFeb 16, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Net income | 138.6 | SEC filingFeb 16, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Common-stock cash dividends | 32.0 | SEC filingFeb 16, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Capital expenditures (PP&E) | 39.4 | SEC filingFeb 16, 2024 |
| Dec 31, 2020From Jan 1, 2020 | Operating cash flow | 203.3 | SEC filingFeb 17, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Net income | 41.9 | SEC filingFeb 17, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Common-stock cash dividends | 31.9 | SEC filingFeb 17, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Capital expenditures (PP&E) | 21.9 | SEC filingFeb 17, 2023 |
| Dec 31, 2019From Jan 1, 2019 | Operating cash flow | 100.1 | SEC filingFeb 18, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Net income | 68.2 | SEC filingFeb 18, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Common-stock cash dividends | 31.2 | SEC filingFeb 18, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Capital expenditures (PP&E) | 26.4 | SEC filingFeb 18, 2022 |